Clinical Study | Office of Clinical Research

A Multi-Center, Phase 2 Study Using A Continual Reassessment Method To Determine The Safety And Tolerability Of 3K3a-Apc, A Recombinant Variant Of Hum

Posted Date: May 15, 2019

Investigator: Opeolu Adeoye
Type of Study: Drug

We are doing this study to learn if the drug 3K3A-APC is safe at different dose levels in people who have had a stroke and who also received either the ?clot buster? drug tPA, or a procedure called mechanical thrombectomy that will use a device to remove or break up a clot in your brain, or both tre

Criteria:

We Are Asking You To Take Part In This Research Study Because You Are Experiencing A Stroke, Which I

Keywords:

Stroke, 3K3a-Apc, Tpa, Blockage Of Blood Fl

For More Information:

Cindy Werner
513-558-0111
cynthia.werner@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List